Naqeeb Mohammad R, Naser Abdallah Y
College of Medicine, Umm Al-Qura University, Makkah, Saudi Arabia.
Department of Applied Pharmaceutical Sciences and Clinical Pharmacy, Faculty of Pharmacy, Isra University, Amman, Jordan.
Clin Optom (Auckl). 2023 Oct 17;15:247-259. doi: 10.2147/OPTO.S433266. eCollection 2023.
Choroidal and retinal disorders significantly contribute to vision impairment, often necessitating hospitalization for the purposes of diagnosis, treatment, and continued care. The aim of this study was to examine hospitalisation trends of choroid and retina diseases in the past 20 years in Australia.
This was an ecological study that used publically available data in Australia from 1998 to 2021. The National Hospital Morbidity Database (NHMD) is an online database that was used to collect the data for this study. We used the chi-squared test to assess the difference between the hospitalisation rates between 1998 and 2021.
During the study period, hospital admission rate for choroid and retina diseases increased by 13.21-fold [from 29.54 (95% CI 28.77-30.32) in 1998 to 419.70 (95% CI 417.21-422.20) in 2021 per 100,000 persons, p<0.001]. Same-day hospital admission patients accounted for 90.3% of the total number of episodes. Rates of same-day hospital admission increased by 37.70-fold [from 9.24 (95% CI 8.81-9.68) in 1998 to 357.78 (95% CI 355.48-360.09) in 2021 per 100,000 persons]. Rates of overnight-stay hospital admission decreased by 19.3% [from 20.34 (95% CI 19.69-20.98) in 1998 to 16.41 (95% CI 15.91-16.90) in 2021 per 100,000 persons]. Females contributed to 54.6% of the total number of hospital admission. Admission rate among females increased by 16.01-fold [from 23.68 (95% CI 22.70-24.66) in 1998 to 402.78 (95% CI 399.33-406.22) in 2021 per 100,000 persons]. Admission rate among males increased by 8.69-fold [from 35.57 (95% CI 34.36-36.78) in 1998 to 344.80 (95% CI 341.58-348.02) in 2021 per 100,000 persons].
In this ecological investigation, we found that the admission rate for choroid and retina disorders increased dramatically. The preponderance of these admissions were made up of females and elderly patients. Future research is required to identify additional risk factors for disorders of this type.
脉络膜和视网膜疾病是导致视力损害的重要原因，通常需要住院进行诊断、治疗和持续护理。本研究旨在调查澳大利亚过去20年脉络膜和视网膜疾病的住院趋势。
这是一项生态学研究，使用了1998年至2021年澳大利亚公开可用的数据。国家医院发病率数据库（NHMD）是一个在线数据库，用于收集本研究的数据。我们使用卡方检验来评估1998年至2021年住院率之间的差异。
在研究期间，脉络膜和视网膜疾病的住院率增长了13.21倍[从1998年每10万人中的29.54（95%可信区间28.77 - 30.32）增至2021年的419.70（95%可信区间417.21 - 422.20），p<0.001]。当日住院患者占总发病数的90.3%。当日住院率增长了37.70倍[从1998年每10万人中的9.24（95%可信区间8.81 - 9.68）增至2021年的357.78（95%可信区间355.48 - 360.09）]。过夜住院率下降了19.3%[从1998年每10万人中的20.34（95%可信区间19.69 - 20.98）降至2021年的16.41（95%可信区间15.9i - 16.90）]。女性占住院总数的54.6%。女性住院率增长了16.01倍[从1998年每10万人中的23.68（95%可信区间22.70 - 24.66）增至2021年的402.78（95%可信区间399.33 - 406.22）]。男性住院率增长了8.69倍[从1998年每10万人中的35.57（95%可信区间34.36 - 36.78）增至2021年的344.80（95%可信区间341.5a - 348.02）]。
在这项生态学调查中，我们发现脉络膜和视网膜疾病的住院率显著增加。这些住院患者中女性和老年患者占多数。需要进一步研究以确定这类疾病的其他风险因素。
